Also found in: Medical, Wikipedia.


An antipsychotic drug, C23H27Cl2N3O2, that functions as a partial dopamine receptor agonist and is used to treat schizophrenia, bipolar disorder, and, in combination with other drugs, depression.

[Perhaps from shortening and alteration of the name of Arvid Carlsson (born 1923), Swedish pharmacologist and Nobel laureate who identified the role of dopamine as a neurotransmitter in the brain and suggested the possibility of developing partial dopamine receptor agonists as treatments for psychosis + pip(e)raz(ine) + -ole.]
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.


n aripiprazol m
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
Mentioned in ?
References in periodicals archive ?
* augmenting the current treatment with the second-generation antipsychotic aripiprazole.
Aripiprazole tablets had annual sales of approximately $182M in Canada, based on IQVIA sales data as of July 2018.
First-generation antipsychotic agents (such as haloperidol) and second-generation antipsychotics (such as aripiprazole, clozapine, olanzapine, quetiapine, risperidone, and ziprasidone) are widely used in the treatment of bipolar disorder.
The Food and Drug Administration has approved aripiprazole lauroxil (Aristada Initio) for the initiation of aripiprazole lauroxil (Aristada) for treating schizophrenia in adults, the drug's developer, Alkermes, announced in a press release.
Participants were randomized to one of three antipsychotics commonly used in children with disruptive behavioral disorders -- oral aripiprazole (49 patients), olanzapine (46 patients), or risperidone (49 patients) -- and were evaluated for 12 weeks.
The researchers focused on five atypical antipsychotics: aripiprazole, ziprasidone, quetiapine, risperidone, and olanzapine.
We hypothesized that we would find space-time clusters where prescribing aripiprazole for bipolar disorder occurred soon after its introduction to the market based on the social contagion mechanism.
The pill, called Abilify MyCite (aripiprazole tablets with a sensor), has been approved for the treatment of schizophrenia, manic and mixed episodes associated with bipolar disorder, and as an add-on treatment for depression.
ABILIFY MYCITE (aripiprazole tablets with sensor) is a digital drug-device combination product comprised of Otsuka's oral aripiprazole tablets embedded with an Ingestible Event Marker (IEM) sensor.
Food and Drug Administration (FDA) granted the first approval of digital medicine system, Abilify MyCite[R] (aripiprazole tablets with sensor), a drug-device combination product comprised of Otsuka's oral aripiprazole tablets embedded with an Ingestible Event Marker (IEM) sensor.
Therefore, I prescribed aripiprazole to facilitate a gradual process of switching medications.